Gene Therapy Cell Culture Media Market Overview:
The global gene therapy cell culture media market size accounted for $122.60 million in 2019, and is expected to reach $278.96 million by 2027, registering a CAGR of 10.6% from 2020 to 2027.
Gene therapies are treatments applicable to a broad range of diseases. They radically treat the cause of the diseases instead of only relieving the symptoms. Furthermore, they may be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several cancers. Gene therapy cell culture media consists of important nutrients that provide ample energy to regulate healthy cell cycle. Moreover, it contains bovine serum, animal-derived nutrients, and growth factors like EGF, FGF, IGF, and PDGF. Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment. The culture media market is anticipated to grow considerably in the near future, owing to different factors such as increase in investments and funding for R&D and innovation in life sciences, especially biopharmaceutical products.
The major factors that contribute toward the growth of the gene therapy cell culture media market include rise in R&D investments, and growth in awareness regarding gene therapy.
Furthermore, factors such as increase in government support, ethical acceptance of gene therapy for cancer treatment, and rise in prevalence of cancer fuel the growth of the market. However, high cost associated with the treatment and unwanted immune responses are expected to hamper the gene therapy cell culture media market growth.
The World Health Organization (WHO) on January 30, 2020, declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe.
By Media Type
Chemically defined media holds a dominant position in 2019
Due to COVID-19 pandemic, the gene therapy cell culture media companies are largely protected from economic disruption, owing to increase in demand for media such as improved protein-free media for growth and production of viral vectors. Rise in demand for COVID vaccine through gene and cell therapy propels the market growth. Furthermore, many gene therapy companies may see the opportunity to find vaccines for Covid-19 as life support which increases the demand for gene therapy cell culture media market as its wider use in clinical trials.
Gene therapy cell culture media market
The gene therapy cell culture media market is segmented on the basis of media type, viral vectors type, end user, and region. By media type is further divided into serum containing media, serum free media, stem cell media, specialty media, chemically defined media, lysogeny broth, custom media, and others. By viral vectors type, the market is divided into retroviruses, lentiviruses, adenoviruses, adeno associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others. By end user, it is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. Region wise, it is analyzed across North America Europe, Asia-Pacific, and LAMEA.
By Viral Vectors Type
Adenoviruses holds a dominant position in 2019
Presently, on the basis of media type, the chemical defined media is the major revenue contributor, and is projected to grow significantly during the forecast period. This is attributed to the repeated purchase of consumables and increased funding for cell-based research. By media type is further divided into serum containing media, serum free media, stem cell media, specialty media, chemically defined media, lysogeny broth, custom media, and others. In addition, the viral vectors are divided into retroviruses, lentiviruses, adenoviruses, adeno associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others.
Depending on end user, the gene therapy cell culture media market is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. Pharmaceutical & Biotechnology industry segment is the major shareholder in the gene therapy cell culture media market, owing to expansion of major pharmaceutical companies, increase in government support and ethical acceptance of gene therapy for cancer treatment.
By End User
Pharmaceutical & Biotechnology industries segment holds a dominant position in 2019
Snapshot of Asia-Pacific gene therapy cell culture media market
Asia-Pacific presents lucrative opportunities for key players operating in the gene therapy cell culture media market, owing to awareness regarding gene therapy for cancer treatment, and rise in prevalence of cancer. The other factors that boost the growth of the market include surge in research funding in the region. Furthermore, focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the cell culture market in the region.
The key players profiled in this report include Fujifilm Holdings Corporation, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Takara Holdings Inc., Novartis International AG, and Bio-Techne Corporation.
Asia-Pacific region would exhibit the highest CAGR of 13.5% during 2020-2027.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the gene therapy cell culture media market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers gene therapy cell culture media market analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of major regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the players are thoroughly analyzed to understand the competitive outlook and global gene therapy cell culture media market growth.
Gene Therapy Cell Culture Media Market Report Highlights
By Media Type
By Viral Vectors Type
By End User
Key Market Players
NOVARTIS INTERNATIONAL AG, MERCK KGAA, SARTORIUS AG, TAKARA HOLDINGS INC. (TAKARA BIO INC.), BIO-TECHNE CORPORATION, FUJIFILM HOLDINGS CORPORATION (FUJIFILM IRVINE SCIENTIFIC), HIMEDIA LABORATORIES, THERMO FISHER SCIENTIFIC, INC., LONZA GROUP LTD, DANAHER CORPORATION (CYTIVA)
According to analyst perspective, the global gene therapy cell culture media market is driven by factors such as increase in funding & investment for R&D activities & innovation in the life science industry, and rise in advancements associated with culture media. However, scientific and ethical concerns associated with culture media and dearth of skilled professionals hamper the growth of the market. The other major factors that contribute toward the growth of the market include launch of novel and advanced instruments and consumables in the market. Further the use of culture media is highest in North America, owing to increased adoption and availability of these products in the U.S., followed by Europe and Asia-Pacific. In addition, key players in this industry focus on expanding their presence in the emerging economies, which is anticipated to drive the market growth.